Insider Transactions in Q1 2023 at Pacific Biosciences Of California, Inc. (PACB)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2023
|
William W. Ericson Director |
SELL
Open market or private sale
|
Direct |
7,541
-28.63%
|
$60,328
$8.9 P/Share
|
Mar 15
2023
|
William W. Ericson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.7%
|
$50,000
$2.54 P/Share
|
Mar 03
2023
|
Mark Van Oene Officer |
SELL
Open market or private sale
|
Direct |
6,268
-0.64%
|
$56,412
$9.49 P/Share
|
Mar 03
2023
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
13,769
-1.11%
|
$123,921
$9.49 P/Share
|
Mar 03
2023
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
5,045
-1.54%
|
$45,405
$9.49 P/Share
|
Mar 03
2023
|
Michele Farmer Officer |
SELL
Open market or private sale
|
Direct |
3,153
-2.72%
|
$28,377
$9.49 P/Share
|
Mar 02
2023
|
Mark Van Oene Officer |
BUY
Grant, award, or other acquisition
|
Direct |
328,500
+25.26%
|
-
|
Mar 02
2023
|
Christian O Henry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
594,687
+32.47%
|
-
|
Mar 02
2023
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
164,200
+33.32%
|
-
|
Mar 02
2023
|
Michele Farmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,100
+31.01%
|
-
|
Mar 02
2023
|
Jeff Eidel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
164,200
+25.87%
|
-
|
Feb 17
2023
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
907
-0.55%
|
$9,070
$10.27 P/Share
|
Feb 17
2023
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
1,530
-0.24%
|
$15,300
$10.27 P/Share
|
Jan 10
2023
|
Mark Van Oene Officer |
SELL
Open market or private sale
|
Direct |
26,722
-4.0%
|
$240,498
$9.53 P/Share
|